Gresham Gwendolyn has filed 15 insider transactions across 1 company since December 2022.
Most recent transaction: a grant/award of 33490 shares of Core Laboratories Inc. /DE/ ($CLB) on February 12, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 12, 2026 | Core Laboratories Inc. /DE/ | $CLB | Gresham Gwendolyn | SVP | A | Performance Shares | 33490 | $0.00 | 33,490.0000 | 47,381,000 | 9999.99% | 0.07% |
| Dec. 31, 2025 | Core Laboratories Inc. /DE/ | $CLB | Gresham Gwendolyn | SVP | M | Common Stock | 24952 | $0.00 | 52,527.0000 | 47,381,000 | 90.49% | 0.05% |
| Dec. 31, 2025 | Core Laboratories Inc. /DE/ | $CLB | Gresham Gwendolyn | SVP | M | Performance Shares | 24952 | $0.00 | 0.0000 | 47,381,000 | 100.00% | 0.05% |
| Dec. 31, 2025 | Core Laboratories Inc. /DE/ | $CLB | Gresham Gwendolyn | SVP | F | Common Stock | 19301 | $16.03 | 33,226.0000 | 47,381,000 | 36.74% | 0.04% |
| Feb. 13, 2025 | Core Laboratories Inc. /DE/ | $CLB | Gresham Gwendolyn | SVP | A | Performance Shares | 32912 | $0.00 | 32,912.0000 | 47,685,000 | 9999.99% | 0.07% |
| Dec. 31, 2024 | Core Laboratories Inc. /DE/ | $CLB | Gresham Gwendolyn | SVP | F | Common Stock | 5989 | $17.31 | 27,575.0000 | 47,820,000 | 17.84% | 0.01% |
| Dec. 31, 2024 | Core Laboratories Inc. /DE/ | $CLB | Gresham Gwendolyn | SVP | M | Common Stock | 9604 | $0.00 | 33,564.0000 | 47,820,000 | 40.08% | 0.02% |
| Dec. 31, 2024 | Core Laboratories Inc. /DE/ | $CLB | Gresham Gwendolyn | SVP | M | Performance Shares | 9604 | $0.00 | 0.0000 | 47,820,000 | 100.00% | 0.02% |
| Feb. 15, 2024 | Core Laboratories Inc. /DE/ | $CLB | Gresham Gwendolyn | SVP | A | Performance Shares | 38002 | $0.00 | 38,002.0000 | 47,523,000 | 9999.99% | 0.08% |
| Dec. 31, 2022 | Core Laboratories Inc. /DE/ | $CLB | Gresham Gwendolyn | SVP | M | Common Stock | 12000 | $0.00 | 19,783.0000 | 0 | 154.18% | 0.00% |
| Dec. 31, 2023 | Core Laboratories Inc. /DE/ | $CLB | Gresham Gwendolyn | SVP | F | Common Stock | 5775 | $17.66 | 23,960.0000 | 46,813,000 | 19.42% | 0.01% |
| Dec. 31, 2022 | Core Laboratories Inc. /DE/ | $CLB | Gresham Gwendolyn | SVP | F | Common Stock | 4722 | $20.27 | 15,061.0000 | 0 | 23.87% | 0.00% |
| Dec. 31, 2023 | Core Laboratories Inc. /DE/ | $CLB | Gresham Gwendolyn | SVP | F | Common Stock | 5643 | $17.66 | 24,092.0000 | 46,813,000 | 18.98% | 0.01% |
| Dec. 31, 2023 | Core Laboratories Inc. /DE/ | $CLB | Gresham Gwendolyn | SVP | M | Performance Shares | 14674 | $0.00 | 0.0000 | 46,813,000 | 100.00% | 0.03% |
| Dec. 31, 2023 | Core Laboratories Inc. /DE/ | $CLB | Gresham Gwendolyn | SVP | M | Common Stock | 14674 | $0.00 | 29,735.0000 | 46,813,000 | 97.43% | 0.03% |